Ambulatory Phlebectomy & Sclerotherapy. Dr. S. Kundu Medical Director The Vein Institute of Toronto

Similar documents
Clinical/Duplex Evaluation of Varicose Veins: Who to Treat?

Medicare C/D Medical Coverage Policy

Vein Disease Treatment

WHAT ABOUT FOAM SCLEROTHERAPY IN REVAS? Dr O CRETON Ste FOY LES LYON

Current Management of Varicose Veins

Additional Information S-55

Chronic Venous Insufficiency Compression and Beyond

RECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY

Chronic Venous Insufficiency

PROVIDER POLICIES & PROCEDURES

Varicose Veins What Are They? Sclerotherapy in the Treatment of Venous Disease Zachary C. Schmittling, MD, FACS May 4, 2018

Patient Information. Venous Insufficiency and Varicose Veins

How to choose which treatment method(s) to use for a particular varicose veins patient ESTABLISHING A TREATMENT PLAN.

Vein & Body Specialists at The Bellevue Hospital Spider Vein and Varicose Vein Treatments

[Kreussler Studies] FDA. multicenter GCP. controlled. randomized. prospective. blinded SUMMARY OF PIVOTAL STUDIES ON SCLEROTHERAPY OF VARICOSE VEINS

Last literature review version 19.3: Fri Sep 30 00:00:00 GMT 2011 This topic last updated: Thu Sep 30 00:00:00 GMT 2010 (More)

Treatment of Varicose Veins

Priorities Forum Statement

INGROWING TOE NAIL REQUIREMENTS A. Instruments to be autoclaved and packed B. Disposables C. Solutions PROCEDURE

Appendix 1 to Direct Vision Sclerotherapy AUSTRALASIAN COLLEGE OF PHLEBOLOGY CLINICAL PROCEDURES. CP Direct Vision Sclerotherapy Clinical procedure

Disclosures. What is a Specialty Vein Clinic? Prevalence of Venous Disease. Management of Venous Disease: an evidence based approach.

AMERICAN PODIATRIC MEDICAL ASSOCIATION

Varicose Vein Information Sheet

Technique of the VenaSeal System

The role of ultrasound duplex in endovenous procedures

Recurrent Varicose Veins We All See Them

BP and Heart Rate by Telemetry

Clinical case. Symptomatic anterior accessory great saphenous vein (AAGSV) reflux

Patient assessment and strategy making for endovenous treatment

TREATMENT OPTIONS FOR CHRONIC VENOUS INSUFFICIENCY

Information about minimally-invasive vein therapy

Number: Policy *Please see amendment for Pennsylvania Medicaid at the end. Last Review 01/12/2017 Effective: 11/20/1995 Next Review: 01/11/2018

PROF S.R.SUBRAMMANIYAN INSTITUTE OF VASCULAR SURGERY MADRAS MEDICAL COLLEGE

Segmental GSV reflux

How varicose veins occur

Initial placement 20FR Guidewire PEG kit REORDER NO:

Treatment of Varicose Veins/Venous Insufficiency

Disclosure. Lowell Kabnick, M.D., FACS, FACPh. I disclose the following financial relationship(s):

Treatment of Varicose Veins/Venous Insufficiency. Description

MEDICAL POLICY SUBJECT: VARICOSITIES, TREATMENT ALTERNATIVES TO VEIN STRIPPING AND LIGATION

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

Varicose Vein Treatments

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: MP.066.MH Last Review Date: 11/08/2018 Effective Date: 01/01/2019

GSV treatment with Radio Frequency EVRF device and CR45i catheter CLINICAL STUDY

Venous Insufficiency Ulcers. Patient Assessment: Superficial varicosities. Evidence of healed ulcers. Dermatitis. Normal ABI.

Love your legs again Varicose Veins

Initial placement 24FR Pull PEG kit REORDER NO:

Expanding Your Vein Business Terri Morrison, RN, B.S., CEO Morrison Vein Institute Scottsdale/Tempe Arizona

Visual Sclerotherapy. 1:24-1:36 Now 10 minutes flying along. Nick Morrison, MD, FACPh, FACS President, International Union of Phlebology

Corporate Medical Policy

MEDICAL POLICY SUBJECT: VARICOSITIES, TREATMENT ALTERNATIVES TO VEIN STRIPPING AND LIGATION. POLICY NUMBER: CATEGORY: Technology Assessment

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

Post-Thrombotic Syndrome(PTS) Conservative Treatment Options

Medical Affairs Policy

Original Policy Date

SAFETY AND FEASIBILITY OF MECHANO-CHEMICAL ABLATION OF VARICOSE VEINS: INITIAL RESULTS

PHLEBOLOGY. Venous Insufficiency. Presentation Use Information

Criteria For Medicare Members. Kaiser Foundation Health Plan of Washington

Evaluation of lidocaine as an analgesic when added to hypertonic saline for sclerotherapy

PROCEDURES FOR SPIDER AND VARICOSE VEINS. Reducing Symptoms and Improving Appearance

Varicose Veins. These are abnormal veins in the legs that appear as unsightly or cause other problems.

UNDERSTANDING VEIN PROBLEMS

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

Date: A. Venous Health History Form. Patient please complete questions Primary Care Physician:

V I U R E V I E W. T h e O f f i c i a l J o u r n a l o f V e n o u s I n s u f f i c i e n c y U n i v e r s i t y

OHTAC Recommendation. Endovascular Laser Treatment for Varicose Veins. Presented to the Ontario Health Technology Advisory Committee in November 2009

Long-term vein diameter reduction by perivenous hyaluronan instead of tumescence for endovenous procedures

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

If viewing a printed copy of this policy, please note it could be expired. Got to to view current policies.

MEDICAL POLICY SUBJECT: VARICOSITIES, TREATMENT ALTERNATIVES TO VEIN STRIPPING AND LIGATION

New Technologies in Superficial Vein Treatment

Date: A. Venous Health History Form. Patient please complete questions Primary Care Physician:

Prevalence. Definition. Chronic Venous Insufficiency. Overview of Chronic Venous Insufficiency

Chest Tube Thoracostomy

Perforators: When to Treat and How Best to Do It? Eric Hager, MD September 10, 2015

Which place for liquid sclerotherapy? Eberhard Rabe Department of Dermatology University of Bonn Germany

VARICOSE VEINS AND VENOUS INSUFFICIENCY

Medical Policy. Description/Scope. Position Statement

Subject: Treatments for Varicose Veins/Venous Insufficiency

DOSAGE FORMS AND STRENGTHS

University of Utah. Cutaneous Nerve Evaluation. Please read through all information BEFORE scheduling patient s biopsy

Treatment of Varicose Veins/Venous Insufficiency

Endothermal Ablation for Venous Insufficiency. Dr. S. Kundu Medical Director The Vein Institute of Toronto

DISCOVER NEW HORIZONS IN FLUID DRAINAGE. Bringing Safety and Convenience to Fluid Drainage Management

Techniques and Specific Treatment Modalities for the Active Non-Healing Wound. Luke Maj, MD, MHA

Treatment of Varicose Veins/Venous Insufficiency

Epidemiology: Prevalence

PACKAGE LEAFLET: INFORMATION FOR THE USER. Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate

Modified Radical Mastectomy

Healthy Never Looked So Good. At the forefront of the latest solutions in vein treatment.

Kathleen Gibson, MD FACS Lake Washington Vascular Surgeons, Bellevue, WA, USA

BlueCross BlueShield of Tennessee Medical Policy Manual

Varicose Vein Treatment

ORIGINAL ARTICLES. Masatoshi Jibiki 1, Tetsuro Miyata 1,2, Sachiko Futatsugi 3, Mitsumasa Iso 3 and Yasutaka Sakanushi 3.

Why Tumescent-Free Therapy Will Replace RF and Laser

Home Health Foundation, Inc. To create more permanent IV access for patients undergoing long term IV therapy.

V I U R E V I E W. T h e O f f i c i a l J o u r n a l o f V e n o u s I n s u f f i c i e n c y U n i v e r s i t y

ABLATIVE AND SURGICAL TREATMENT FOR VENOUS INSUFFICIENCY

Management of Superficial Reflux: Which option, when? Kathleen Gibson, MD Lake Washington Vascular Surgeons Bellevue, WA

Transcription:

Ambulatory Phlebectomy & Sclerotherapy Dr. S. Kundu Medical Director The Vein Institute of Toronto 1

Disclosures Consultant: Bard Canada Boston Scientific Canada Edwards Life Sciences Baylis Canada Sigmacon Diomed Dornier 2

Definition Other Names: Stab Avulsion Micro Extraction Definition: Removal of segments of varicose veins of any size and from any location, under local anesthesia, on an outpatient basis 3

Introduction Varicosities of any size in any location Exclusion = reflux at SFJ Can be combined with other methods EVLT/EVLA/ELAS/RFA Sclerotherapy Diagnostic workup essential 4

Indications-1 Asymptomatic Varicose Veins Cosmetic purposes Concern about sequelae of varicose veins Strong family history of varicose veins & complications Symptomatic Varicose Veins Complicated Varicose Veins 5

Indications-2 Large varicosities widespread Thicker varicose veins (non-blue) Side branches GSV & SSV Younger active patients Dorsal foot veins Lipodermatosclerosis 6

Contraindications Infectious dermatitis or cellulitis of the area to be treated Severe peripheral edema Secondary to: Cardiac disease Renal disease Seriously ill patients Severe cardiovascular and/or pulmonary problems Uncontrolled diabetes Very elderly patients 7

Technique Rule out reflux at saphenofemoral or saphenopopliteal junction reflux Preoperative mapping Surgical planning Local Anesthesia Phlebectomy Postoperative dressing 8

Rule Out Reflux Duplex ultrasound Assess for saphenofemoral and saphenopoliteal junction reflux If ultrasound positive for reflux Perform EVLA/ELAS/EVLT/RFA first Always treat proximal to distal 9

Preoperative Mapping Use surgical pen or permanent marker Have patient stand for 20 minutes before marking Initial mapping performed in standing position Secondary mapping performed in Trendelenburg position using transillumination 10

Preoperative Mapping 11

Preoperative Mapping 12

Preoperative Mapping 13

Preoperative Mapping 14

Transillumination Light 15

Local Anesthesia Start with 1% lidocaine/xylocaine Initiation points for tumescent anesthesia Use 25 gauge, ½ inch needle Tumescent anesthesia Dilute lidocaine with epinephrine 1 in 4 0.25 % Lidocaine Volume up to 500 ml Inject slowly using 30 cc syringe Use 20 gauge spinal needle 16

Tumescent Anesthesia 17

Ambulatory Phlebectomy Instrumentation Variety of hooks Muller, Oesch, Ramlet, Varaday, Dortu Small curved hemostats Blunt dissector (may use hooks) #11 blade, opthalmology blade, 18 gauge needle Sterile gauze, drapes Scissors 18

Ambulatory Phlebectomy Instrumentation 19

Ambulatory Phlebectomy Instrumentation 20

Ambulatory Phlebectomy Technique-1 Puncture skin using scalpel or needle Dissection along long axis Hook or Harpoon adventitia-attempt to lift Visualize glistening white 21

Ambulatory Phlebectomy Technique 22

Ambulatory Phlebectomy Technique-2 Exteriorize vein loop Grasp loop with mosquito hemostat Gentle slow pull with lateral massage Hemostats advanced Traction maintained to guide next site Skin Tenting can guide next site 23

Ambulatory Phlebectomy Technique 24

Ambulatory Phlebectomy Technique 25

Ambulatory Phlebectomy Technique-3 When difficult to extract move to next site Multiple vein loops exteriorized initially Connected by blunt dissection Avulsion usually in portions Bleeding compressed by assistant 26

Ambulatory Phlebectomy Technique 27

Ambulatory Phlebectomy Post-Op Care Incisions sealed with Steri-strips No sutures Gauze pads or other absorbent pads placed over incision sites Short Stretch Bandage Graduated compression stocking 30-40 mm Hg Duration- one week 28

Ambulatory Phlebectomy Cases 29

Ambulatory Phlebectomy Cases 30

Sclerotherapy Types of Solutions Concentrations based on vein size Equipment 31

Types of Solutions Detergent Solutions Sodium Tetradecyl Sulfate (STS) Sotadecrol Polidocanol (POL) Aethoxysklerol Ethanolamine Oleate (Ethamolin) Sodium Morrhuate (Scleromate) 32

Types of Solutions Toxic or Corrosive Agents Iodine salt (polyiodinated) (P2) Sclerodyne Glycerin (chromium potassium alum) Chromex Alcohols Metal Compounds 33

Detergent Solutions Mechanism of Action Fast Acting Dissolution of endothelium cell membrane Moderate penetration depth May have effect up to 20 cm from injection site Stimulation of inflammation sequences 34

Detergent Solutions Advantages Painless when intravascular Effects beyond injection point Affect large networks efficiently Large amount of territory per treatment All size vessels treatable Inflammatory component controllable by varying concentration FDA approval for STS 35

Detergent Solutions Disadvantages Allergy STS dissolves rubber stoppers Must use Latex free syringes Long length of action Expense 36

Sclerosing Solution Matched to Vessel Size Telangiectasias/Spider Veins 0.1% to 0.2% sodium tetradecyl sulfate (STS) Non-foam Less than 0.5 ml volume Reticular Veins 0.25 to 0.5% sodium tetradecyl sulfate (STS) Foam: 0.25% Volume up to 0.5 cc per injection site 37

Sclerosing Solutions- Larger Vessels Large Reticular/Small Varicose Veins 0.5% to 1% STS conventional 0.5% foam Injection of up to 1cc per site. No more than 10cc per session Truncal Varicose Veins 3% STS conventional 1% STS Foam Up to 3cc of 3% may be used in one session 38

Maximum Doses per Session 10 ml rule Hyperosmolar = 10 ml Detergent = 10 ml of 3 % (strongest) 39

Equipment 3 cc syringe for spider and reticular veins 5 cc syringe for small varicose and truncal varicose veins 27 butterfly or 30 needle Three way stopcock Transillumination Light Marker 40

Equipment 41

Compression Guidelines Spider Veins & Reticular Veins 20-30 mm Hg Reticular & Small Varicose Veins 20-30 mm Hg Truncal Varicose Veins 30-40 mm Hg All compression for two to three weeks 42